Loading…

Diagnosis and management of dementia with Lewy bodies: current recommendations and unsolved issues

Dementia with Lewy bodies is considered to be the second most common, after Alzheimer’s disease, cause of primarily degenerative dementias. Dementia with Lewy bodies, despite being quite common (according to epidemiological and clinicopathological studies), is still relatively rarely diagnosed in ge...

Full description

Saved in:
Bibliographic Details
Published in:Aktualności neurologiczne 2013-01, Vol.13 (4), p.308
Main Authors: Sobów, Tomasz, Magierski, Radosław
Format: Article
Language:eng ; pol
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 4
container_start_page 308
container_title Aktualności neurologiczne
container_volume 13
creator Sobów, Tomasz
Magierski, Radosław
description Dementia with Lewy bodies is considered to be the second most common, after Alzheimer’s disease, cause of primarily degenerative dementias. Dementia with Lewy bodies, despite being quite common (according to epidemiological and clinicopathological studies), is still relatively rarely diagnosed in general practice. Wrong diagnoses of Alzheimer’s and Parkinson’s diseases are the commonest diagnostic errors, psychosis (usually attributed solely to aging process) being an alternative. Incorrect diagnosis results in ineffective treatment, and because of hypersensitivity to even small doses of antipsychotic drugs in DLB cases, treatment often could be extremely dangerous. Differential diagnosis includes differentiation with other primarily neurodegenerative dementias, including the closest phenotypically – Alzheimer’s disease with parkinsonism and dementia in Parkinson’s disease. Differentiation and giving of the correct diagnosis facilitates the use of clinical diagnostic criteria and additional tests. The most important issue is finding the characteristic clinical picture of psychiatric and neurologicalpresentation and the sequence of the onset of dementia and parkinsonism. Optimal improvement in majority of patients is possible with correct diagnosis and the use of strategies from the border of neurology and psychiatry. Cholinesterase inhibitors are mainstream treatment option for cognitive dysfunction (also some behavioural improvement, psychosis included, might be achieved) while levodopa is used for motor symptoms control. Antipsychotics must be used very cautiously and the first-line choice is currently quetiapine. An important issue is the treatment of coexisting REM-sleep disorder and autonomic dysfunction.
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2708648203</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2708648203</sourcerecordid><originalsourceid>FETCH-proquest_journals_27086482033</originalsourceid><addsrcrecordid>eNqNjMkOgjAURRujiUT5h5e4JqGlTG4d4sKle1NowRpotQ8k_r04fICre5JzcifEYzymQZjkyZR4NOE0yBlL58RH1EUY04zGOU89Umy1qI1FjSCMhFYYUatWmQ5sBfJDWsCguwsc1fCEwkqtcA1l79y7cqq07VhJ0Wlrvie9Qds8lASN2CtcklklGlT-bxdktd-dNofg5ux99N35antnRnVmaZglPGNhFP1XvQCu_Uh4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2708648203</pqid></control><display><type>article</type><title>Diagnosis and management of dementia with Lewy bodies: current recommendations and unsolved issues</title><source>Publicly Available Content (ProQuest)</source><creator>Sobów, Tomasz ; Magierski, Radosław</creator><creatorcontrib>Sobów, Tomasz ; Magierski, Radosław</creatorcontrib><description>Dementia with Lewy bodies is considered to be the second most common, after Alzheimer’s disease, cause of primarily degenerative dementias. Dementia with Lewy bodies, despite being quite common (according to epidemiological and clinicopathological studies), is still relatively rarely diagnosed in general practice. Wrong diagnoses of Alzheimer’s and Parkinson’s diseases are the commonest diagnostic errors, psychosis (usually attributed solely to aging process) being an alternative. Incorrect diagnosis results in ineffective treatment, and because of hypersensitivity to even small doses of antipsychotic drugs in DLB cases, treatment often could be extremely dangerous. Differential diagnosis includes differentiation with other primarily neurodegenerative dementias, including the closest phenotypically – Alzheimer’s disease with parkinsonism and dementia in Parkinson’s disease. Differentiation and giving of the correct diagnosis facilitates the use of clinical diagnostic criteria and additional tests. The most important issue is finding the characteristic clinical picture of psychiatric and neurologicalpresentation and the sequence of the onset of dementia and parkinsonism. Optimal improvement in majority of patients is possible with correct diagnosis and the use of strategies from the border of neurology and psychiatry. Cholinesterase inhibitors are mainstream treatment option for cognitive dysfunction (also some behavioural improvement, psychosis included, might be achieved) while levodopa is used for motor symptoms control. Antipsychotics must be used very cautiously and the first-line choice is currently quetiapine. An important issue is the treatment of coexisting REM-sleep disorder and autonomic dysfunction.</description><identifier>ISSN: 1641-9227</identifier><identifier>EISSN: 2451-0696</identifier><language>eng ; pol</language><publisher>Warsaw: Medical Communications Sp. z o.o</publisher><subject>Alzheimer's disease ; Dementia ; Parkinson's disease ; Psychosis ; REM sleep</subject><ispartof>Aktualności neurologiczne, 2013-01, Vol.13 (4), p.308</ispartof><rights>2013. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2708648203?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,37012,44590</link.rule.ids></links><search><creatorcontrib>Sobów, Tomasz</creatorcontrib><creatorcontrib>Magierski, Radosław</creatorcontrib><title>Diagnosis and management of dementia with Lewy bodies: current recommendations and unsolved issues</title><title>Aktualności neurologiczne</title><description>Dementia with Lewy bodies is considered to be the second most common, after Alzheimer’s disease, cause of primarily degenerative dementias. Dementia with Lewy bodies, despite being quite common (according to epidemiological and clinicopathological studies), is still relatively rarely diagnosed in general practice. Wrong diagnoses of Alzheimer’s and Parkinson’s diseases are the commonest diagnostic errors, psychosis (usually attributed solely to aging process) being an alternative. Incorrect diagnosis results in ineffective treatment, and because of hypersensitivity to even small doses of antipsychotic drugs in DLB cases, treatment often could be extremely dangerous. Differential diagnosis includes differentiation with other primarily neurodegenerative dementias, including the closest phenotypically – Alzheimer’s disease with parkinsonism and dementia in Parkinson’s disease. Differentiation and giving of the correct diagnosis facilitates the use of clinical diagnostic criteria and additional tests. The most important issue is finding the characteristic clinical picture of psychiatric and neurologicalpresentation and the sequence of the onset of dementia and parkinsonism. Optimal improvement in majority of patients is possible with correct diagnosis and the use of strategies from the border of neurology and psychiatry. Cholinesterase inhibitors are mainstream treatment option for cognitive dysfunction (also some behavioural improvement, psychosis included, might be achieved) while levodopa is used for motor symptoms control. Antipsychotics must be used very cautiously and the first-line choice is currently quetiapine. An important issue is the treatment of coexisting REM-sleep disorder and autonomic dysfunction.</description><subject>Alzheimer's disease</subject><subject>Dementia</subject><subject>Parkinson's disease</subject><subject>Psychosis</subject><subject>REM sleep</subject><issn>1641-9227</issn><issn>2451-0696</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNjMkOgjAURRujiUT5h5e4JqGlTG4d4sKle1NowRpotQ8k_r04fICre5JzcifEYzymQZjkyZR4NOE0yBlL58RH1EUY04zGOU89Umy1qI1FjSCMhFYYUatWmQ5sBfJDWsCguwsc1fCEwkqtcA1l79y7cqq07VhJ0Wlrvie9Qds8lASN2CtcklklGlT-bxdktd-dNofg5ux99N35antnRnVmaZglPGNhFP1XvQCu_Uh4</recordid><startdate>20130101</startdate><enddate>20130101</enddate><creator>Sobów, Tomasz</creator><creator>Magierski, Radosław</creator><general>Medical Communications Sp. z o.o</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M2M</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20130101</creationdate><title>Diagnosis and management of dementia with Lewy bodies: current recommendations and unsolved issues</title><author>Sobów, Tomasz ; Magierski, Radosław</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_27086482033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; pol</language><creationdate>2013</creationdate><topic>Alzheimer's disease</topic><topic>Dementia</topic><topic>Parkinson's disease</topic><topic>Psychosis</topic><topic>REM sleep</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sobów, Tomasz</creatorcontrib><creatorcontrib>Magierski, Radosław</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Psychology Database (ProQuest)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Aktualności neurologiczne</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sobów, Tomasz</au><au>Magierski, Radosław</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnosis and management of dementia with Lewy bodies: current recommendations and unsolved issues</atitle><jtitle>Aktualności neurologiczne</jtitle><date>2013-01-01</date><risdate>2013</risdate><volume>13</volume><issue>4</issue><spage>308</spage><pages>308-</pages><issn>1641-9227</issn><eissn>2451-0696</eissn><abstract>Dementia with Lewy bodies is considered to be the second most common, after Alzheimer’s disease, cause of primarily degenerative dementias. Dementia with Lewy bodies, despite being quite common (according to epidemiological and clinicopathological studies), is still relatively rarely diagnosed in general practice. Wrong diagnoses of Alzheimer’s and Parkinson’s diseases are the commonest diagnostic errors, psychosis (usually attributed solely to aging process) being an alternative. Incorrect diagnosis results in ineffective treatment, and because of hypersensitivity to even small doses of antipsychotic drugs in DLB cases, treatment often could be extremely dangerous. Differential diagnosis includes differentiation with other primarily neurodegenerative dementias, including the closest phenotypically – Alzheimer’s disease with parkinsonism and dementia in Parkinson’s disease. Differentiation and giving of the correct diagnosis facilitates the use of clinical diagnostic criteria and additional tests. The most important issue is finding the characteristic clinical picture of psychiatric and neurologicalpresentation and the sequence of the onset of dementia and parkinsonism. Optimal improvement in majority of patients is possible with correct diagnosis and the use of strategies from the border of neurology and psychiatry. Cholinesterase inhibitors are mainstream treatment option for cognitive dysfunction (also some behavioural improvement, psychosis included, might be achieved) while levodopa is used for motor symptoms control. Antipsychotics must be used very cautiously and the first-line choice is currently quetiapine. An important issue is the treatment of coexisting REM-sleep disorder and autonomic dysfunction.</abstract><cop>Warsaw</cop><pub>Medical Communications Sp. z o.o</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1641-9227
ispartof Aktualności neurologiczne, 2013-01, Vol.13 (4), p.308
issn 1641-9227
2451-0696
language eng ; pol
recordid cdi_proquest_journals_2708648203
source Publicly Available Content (ProQuest)
subjects Alzheimer's disease
Dementia
Parkinson's disease
Psychosis
REM sleep
title Diagnosis and management of dementia with Lewy bodies: current recommendations and unsolved issues
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T19%3A44%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnosis%20and%20management%20of%20dementia%20with%20Lewy%20bodies:%20current%20recommendations%20and%20unsolved%20issues&rft.jtitle=Aktualno%C5%9Bci%20neurologiczne&rft.au=Sob%C3%B3w,%20Tomasz&rft.date=2013-01-01&rft.volume=13&rft.issue=4&rft.spage=308&rft.pages=308-&rft.issn=1641-9227&rft.eissn=2451-0696&rft_id=info:doi/&rft_dat=%3Cproquest%3E2708648203%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_27086482033%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2708648203&rft_id=info:pmid/&rfr_iscdi=true